Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 165.00 | |
2 mg | In stock | $ 229.00 | |
5 mg | In stock | $ 338.00 | |
10 mg | In stock | $ 498.00 | |
25 mg | In stock | $ 812.00 | |
50 mg | In stock | $ 1,130.00 | |
100 mg | In stock | $ 1,520.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 448.00 |
Description | Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively. |
Targets&IC50 | Raf:7.0 nM, VEGFR2:2.2 nM |
Molecular Weight | 547.99 |
Formula | C27H19ClFN5O3S |
CAS No. | 1125632-93-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/ml (118.62 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Takeda-6d 1125632-93-0 Angiogenesis Tyrosine Kinase/Adaptors VEGFR antitumor HUVEC cells inhibit antiangiogenesis Raf Vascular endothelial growth factor receptor PKR-like endoplasmic reticulum kinase orally active Takeda-6D Inhibitor Takeda 6d PERK Takeda6d Raf kinases Protein kinase R-like endoplasmic reticulum kinase inhibitor